NovaQuest’s Azurity acquires Arbor Pharmaceuticals from JW Asset Management and KKR

The combined company, operating as Azurity, will have a portfolio of products serving the unmet needs of patients in the cardiovascular, central nervous system, endocrinological, gastrointestinal, and institutional markets.